Summary.-Peripheral leucocytes from nasopharyngeal carcinoma (NPC) patients and control subjects, which included healthy subjects and patients with other cancers, have been tested against PPD and a panel of extracts from Raji cells and pooled NPC biopsies, using the blast transformation and the macrophage migration inhibition assays. The results of both assays indicated that the in vitro cell-mediated immune (CMI) responses to the Raji-cell extracts and NPC-biopsy extracts were associated with NPC. However, the peripheral leucocytes from NPC patients and control subjects responded similarly to PPD. These results are in general accord with the skin tests reported by Levine et al. (1976) and Ho, Ng and Kwan (1977b) . The antigenic specificity of the NPC-associated CMI responses remains, however, to be resolved, as the extracts used in these or in the in vivo CMI studies were heterogeneous mixtures.
NPC is closely associated with EpsteinBarr virus (EBV). This is made evident by: (1) NPC patients showing a different pattern of humoral immune responses to EBV antigens from that shown by control groups of non-NPC subjects (Henle et al., 1970; Henle et al., 1973; de Schryver et al., 1974; de-The et al., 1975; Ho et al., 1977b; Ng, Ho and Kwan, 1977) and (2) the persistent presence of EBV genomes and EBV nuclear antigen(s) in NPC cells (Desgranges et al., 1975; Huang et al., 1974; Wolf, Zur Hausen and Becker, 1973; Klein et al., 1974) . The resident EBV genomes may be activated to synthesize early viral antigens and/or virus particles when NPC cells have been treated with IUdR and BUdR respectively (Glaser et al., 1976; Trumper, Epstein and Giovanella, 1976) . A transforming strain of EBV was frequently found to stimulate sustained cell outgrowth from normal nasopharyngeal epithelial explants infected in vitro with this virus. Stimulation was, however, more rarely observed with similarly treated explants from tonsillar mucosa, NPC or OC (other cancer) biopsy specimens (Huang et al., 1977) . These observations suggest that EBV might be a causal agent in NPC.
In view of the above, NPC patients may be expected to have acquired CMI against EBV antigens; as was indeed suggested by the results of in vivo CMI studies of Levine et al. (1976) and Ho et al. (1977a) . Chu et al. (1967) showed that lymphocytes of NPC patients were cytotoxic to autochthonous tumour cells, and suggested that therefore an NPCrelated CMI may also exist. A detailed knowledge of antigenic specificities of the NPC-related and the EBV-related CMI would be of importance. There are two classes of EBV antigens which occur in different lymphoblastoid cell lines harbouring EBV genomes. One is produced during viral lytic cycle and occurs in producer cell lines and, to a lesser extent, in non-producer cell lines treated with halogenated nucleotides (Hampar et al., 1973; Gerber, 1972) or exogenous EBV (Henle, Henle and Klein, 1971) . The other class of EBV antigens (i.e. EB nuclear antigen (EBNA) occurs in both producer and untreated non-producer cell lines, such as Raji (Reedman and Klein, 1973) , and these antigens are not associated with the lytic cycle of the virus. Lai, Alpers and MackayScollay (1975) (Ho et al., 1977b) and it nmay be anticipated that both groups of subjects are also likely to have acquired CMI to the P3HR-I extracts. Nkrumah et al. (1976) reported that patients with Burkitt's lymphoma showed a positive skin reaction against a membrane extract of Raji cell, aind that the antigenic specificities of such reactivity did not appear to be directed against EBNA. Cytotoxic effector cells specific for Raji cells have also been found in the peripheral blood of patients with infectious mononucleosis during the acute phase of the disease (Svedmyr and Jondal, 1975) . It seems possible from these studies and from others with animal tumour viruses (Habel, 1969) that there may exist a new class of plasmamembrane-associated EBV antigens which has not yet been defined serologically. In view of the close association of NPC with EBV, it is of obvious interest to study in vitro CMI to the latter class of antigens, and to test its possible relationship with CMI against NPC cells. To this end, we have prepared extracts from Raji cells by ionic-shock treatments which result in the release of a heterogeneous mixture of cell-surface proteins (Lo et al., 1976 Biological Corp., U.S.A.) and suspended in growth medium at a cell density of 0-6-0-8 x 106 cells/ml. 0 4 ml aliquots of this cell suspension w%ere cultured in triplicate, in the presence or absence of 0-1 ml of antigen, for 5 days at 37°C in 5% CO2.
The culture supernatants wrere kept at -20°C for the macrophage migration inhibition (MIF) assay while the cells were resuspended in 0 5 ml of growth medium and labelled for 16 h with 5 juCi of 3H-thymidine (TdR) which has a specific radioactivity of 13 Ci/mM TdR (The Radiochemical Centre, Amersham, England). The cells were harvested, washed once with HBSS, dissolved in 0-1 M NaOH and precipitated in 500 trichloroacetic acid (TCA) after neutralization of the solution with IM HCl. The precipitated material was collected onto GF/C glass-fibre filters (2.4 cm, Whatman Ltd, England) and its radioactivity counted in a liquid scintillator using 5 ml of scintillation fluid (Aquasol, New England Nuclear, U.S.A.). BT response was expressed as stimulation index (SI) which is the ratio of the average radioactivity incorporated by the test to that by the control cultures.
Macrophage migration inhibition assay.-This was performed as described by Rocklin, Meyers and David (1970) . The culture supernatants were used undiluted. For each batch of guinea-pig macrophage used, controls were set up using the antigens or the extracts adjusted to the same concentration as used in the leucocyte cultures (reconstituted antigen controls). The extent of macrophage migration in the presence of the culture supernatant or the reconstituted antigens was compared with and expressed as a percentage of that observed with the macrophage alone.
Subjects.-80 NPC and 77 OC patients with histologically confirmed cases of the respective cancers and 21 HS were studied. The average age and the sexes of each of these groups of subjects are summarized in Table I .
Antigen and extracts.-The Raji-cell extracts were prepared with cells harvested from cultures at log phase of growth according to Lo et al. (1976) . TS were obtained by treating these cells with the Tris-HCl buffer (Tris-HCl, 0O02M in 10% glycerol, pH 7.2). These cells were further treated with the EDTA buffer (Tris-HCl, 0-02M; EDTA, 10 mM; NaCl, 0-2M; pH 7.2) and the resulting extract is referred to as ES. These extracts had been shown to consist mainly of surface components from Raji cells (Lo et al., 1976 (Type C), or only BT (Type D) assays (i.e. the discordant responses). The mean ratio of patients showing the concordant and discordant responses observed with PPD and the extracts depended on the SI cut-off values (Fig. 2) . The maximum ratio occurred at a cut-off value of 1.6, (Fig. 3) 
DISCUSSION
The blast transformation (BT) assay, particularly when adapted for microcultures, provides a convenient means of testing for in vitro CMI, but the evaluation of data so obtained presents certain difficulties. One concerns the different levels of spontaneous activity of the control unstimulated cultures, which make it necessary, as in the present instance, to measure BT responses in terms of SI rather than the absolute amount of radioactivity incorporated. The choice of a cut-off value to score BT responses presents yet another difficulty. To apply this assay to the evaluation of the CMI of an individual against a known antigen, a large-scale population study should first be carried out. From the results thus obtained, density functions of SI's from a sensitized and nonsensitized populations may be generated. An appropriate cut-off value of SI may Among the concordant responders, a preponderance of the NPC patients showed positive MIF and BT responses to all 4 extracts, while the OC patients almost uniformly showed a negative response. In the larger series using the BT assay alone, the distribution patterns of SI values observed with the NPC patients and the control subjects using these extracts were found to be significantly different by Wilcoxon's two-sample ranksum test. There was also a significantly greater number of NPC patients than control subjects showing positive BT responses (SI > 1.6) to each of the 4 extracts. A positive response to the biopsy extracts (2PE and 12PE) appeared Levine et al. (1976) and Ho et al. (1977b) . Both groups of authors observed that there was a significantly greater number of NPC patients than control subjects who showed positive skin reactivity to the membrane extract of the EBV-carrying lymphoblastoid cell line, HKLy28. In a longitudinal study of NPC patients following radiation therapy (RT), Ho et al. (1977b) observed 2 predominant patterns of changes in the skin reactivity to the HKLy28 extracts. A positive initial skin reaction to the HKLy28 extract, becoming negative after RT, was frequently associated with a good prognosis, while a preponderance of NPC patients with a bad prognosis after RT showed persistence of a positive skin reaction throughout the period of observation. Our observations with the biopsy extracts were also in harmony with the results of Chu et al. (1967) which suggested the existence of NPCrelated CMI. The antigenic specificity of the NPC associated CMI observed with both types of extract is of obvious interest. However, as the extracts thus far used to demonstrate such CMI status were heterogeneous mixtures, the question of antigenic specificity must therefore await studies (now in progress) using purified fractions of these extracts. We are also testing similar extracts of the EBV-negative lymphoblastoid BJAB cells, and of biopsy specimens obtained from the primary tumour sites of patients with other cancers, in order to further characterize the NPC-associated CMI observed with our present extracts and to see whether it is NPC-or EBV-related or both.
The present observations with PPD accord with those of who used extracts of trichophyton and monilia as the recall antigens. In both instances, no apparent differences were observed between the CMI responses of NPC and control subjects to these recall antigens. Chan et al. (1976) however, observed that the responses of peripheral leucocytes from NPC patients to PHA stimulation and their skin reactions to PPD were less than those from control subjects. The reason for such apparent discrepancy remains to be resolved.
